Conference Description
The Nucleosides, Nucleotides and Oligonucleotides GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators.
The 2025 GRS will focus on the latest advances and challenges in the burgeoning field of nucleosides, nucleotides and oligonucleotides. Scientific sessions will cover topics such as novel oligonucleotide synthetic strategies, discovery and development of nucleosides and oligonucleotides therapeutics, molecular recognition of DNA and RNA, new chemical biology and structural tools for nucleic acids, as well as advancements in genome editing and targeted gene therapy. The scientific program will feature three themed sessions, including a keynote lecture and a mentorship panel comprised of diverse representatives from academia and industry, focusing on career development and professional growth.
An outline of the program components for this GRS is displayed below. The seminar chair is currently developing their detailed program schedule, which will include the speakers they select from submitted abstracts, in addition to any additional components outlined below. The detailed program will be available by May 6, 2025. Please check back for updates.
Keynote Speaker
Speakers
- To Be Selected from Submitted Abstracts
Discussion Leaders
- To Be Selected from Submitted Abstracts
Mentorship Component
- "Exploring Career Paths: Perspectives from Academia, Industry, and Start-Ups"
